Spruce Biosciences, Inc.
SPRB
$0.0649
-$0.001-1.52%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 15.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 15.78% | |||
| Cost of Revenue | -49.49% | 227.39% | |||
| Gross Profit | 47.80% | -248.79% | |||
| SG&A Expenses | 10.29% | -4.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.50% | 147.46% | |||
| Operating Income | 39.80% | -155.89% | |||
| Income Before Tax | 40.40% | -171.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.40% | -171.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.40% | -171.70% | |||
| EBIT | 39.80% | -155.89% | |||
| EBITDA | 39.80% | -156.07% | |||
| EPS Basic | 43.72% | -170.46% | |||
| Normalized Basic EPS | 43.71% | -170.43% | |||
| EPS Diluted | 43.72% | -170.46% | |||
| Normalized Diluted EPS | 43.71% | -170.43% | |||
| Average Basic Shares Outstanding | 5.90% | 0.47% | |||
| Average Diluted Shares Outstanding | 5.90% | 0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||